Kyung Chu
Adult Health · Belleville, NJNPI 1962724393
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,275 of the $10,616 with a category attached, or 77.9%. It is spread thinly across 58 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 420 payments — averaging $25.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- AstraZeneca$1K
- E.r. Squibb & Sons, L.L.C.$1K
- TG Therapeutics, Inc.$688
- Incyte Corporation$613
- Johnson & Johnson$584
- plus $5K from 52 others
What the payments were for
- Speaking & faculty fees$6886%
- Food & beverage$8,27578%
- Education$3744%
- Other$1,28012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,616 in reported general payments places this provider in the 95th percentile of 1,135 adult health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RevlimidLenalidomide | 24 | $437,478 |
| LenvimaLenvatinib Mesylate | 15 | $356,813 |
| CabometyxCabozantinib S-Malate | 14 | $339,487 |
| TasignaNilotinib Hcl | 14 | $279,320 |
| VenclextaVenetoclax | 18 | $270,495 |
| NubeqaDarolutamide | 18 | $250,435 |
| NinlaroIxazomib Citrate | 17 | $215,347 |
| TagrissoOsimertinib Mesylate | 12 | $202,972 |
| Lenalidomide | 15 | $190,900 |
| BrukinsaZanubrutinib | 13 | $174,185 |
| EliquisApixaban | 136 | $112,474 |
| XareltoRivaroxaban | 19 | $13,811 |
| Fondaparinux Sodium | 12 | $9,824 |
| Ondansetron Hcl | 92 | $2,399 |
| Anastrozole | 81 | $1,838 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bristol Myers SquibbRevlimid | $76 | $437,47824 claims |
| Eisai Inc.Lenvima | $90 | $356,81315 claims |
| NovartisTasigna | $1,588 | $279,32014 claims |
| AbbVieVenclexta | $377 | $270,49518 claims |
| BayerNubeqa | $191 | $250,43518 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Ninlaro | $186 | $215,34717 claims |
| AstraZenecaTagrisso | $1,291 | $202,97212 claims |
| Beigene USA, Inc.Brukinsa | $76 | $174,18513 claims |
| PfizerEliquis | $197 | $112,474136 claims |
| Johnson & JohnsonXarelto | $584 | $13,81119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,135 adult health providers in New Jersey.
Other adult health in Belleville
- June HalperHackensack$358K
- Kara SaggiomoCamden$127K
- Entela AhmetiPomona$75K
- Phyllis McKiernanHackensack$72K
- Denise ForceMiddletown$71K
- Kathleen SenecaHillsborough$64K
- Diane AndresenNorthvale$60K
- Dana BeenstockFreehold$51K
- Phyllis DudaCamden$46K
- Anthony WalkoWestwood$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.